Filing Flows › DarioHealth (DRIO) › Q2 2026 › vs Q1 2026
DarioHealth (DRIO) Q2 2026 vs Q1 2026 (quarter over quarter)
DarioHealth's revenue fell $407K (-7%) from $5.6M in Q1 2026 to $5.2M in Q2 2026. The biggest changes: Services −$241K (-9%); Hardware and Consumable Products −$166K (-6%).
DarioHealth, Q2 2026: revenue $5.2M (-4% year over year), operating margin -125.1%, net loss $7.9M, operating cash flow −$6.1M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Hardware and Consumable Products | $2.6M | $2.8M | −$166K | -6% |
| Services | $2.6M | $2.8M | −$241K | -9% |
| Revenue | $5.2M | $5.6M | −$407K | -7% |
| Net loss | $7.9M | $8.2M | −$325K | -4% |
| Costs & expenses | $13.1M | $13.8M | −$732K | -5% |
| Operating costs | $11.7M | $12.9M | −$1.2M | -10% |
| Interest & other, net | $1.1M | $883K | $234K | +27% |
| Income tax | $328K | $57K | $271K | +475% |
| Cost of revenue | $2.0M | $2.4M | −$399K | -17% |
| Research & development | $2.1M | $2.4M | −$285K | -12% |
| Sales & marketing | $5.0M | $4.9M | $73K | +1% |
| General & admin | $2.6M | $3.2M | −$626K | -19% |
| Operating cash sources | $7.9M | $8.2M | −$325K | -4% |
| Depreciation & amortization | $515K | $524K | −$9K | -2% |
| Share-based compensation | $632K | $1.4M | −$809K | -56% |
| Working capital & other | $694K | $259K | $435K | +168% |
| Cash used in operations | $6.1M | $6.0M | $58K | +1% |
| Net loss absorbed | $7.9M | $8.2M | −$325K | -4% |
Questions
How much did DarioHealth's revenue grow quarter over quarter in Q2 2026?
DarioHealth's revenue fell $407K (-7%) from $5.6M in Q1 2026 to $5.2M in Q2 2026.
What drove DarioHealth's revenue change in Q2 2026?
Services −$241K (-9%); Hardware and Consumable Products −$166K (-6%).